← Browse by Condition
Medical Condition

salivary gland carcinoma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT03942653 Phase 2
Recruiting

Androgen Deprivation Therapy (ADT) and Pembrolizumab for Advanced Stage Androgen Receptor-positive Salivary Gland Carcinoma

Enrollment
20 pts
Location
United States
Sponsor
Manish Patel
View Trial →